#ABSBrachy25 kicks off with American Brachy president Mira Keyes and special guest ASTRO president Sameer Keole! #ThisIsBrachytherapy #radonc Expanding #brachytherapy research with new and old friends in the Music City #nashville

#ABSBrachy25 new technologies EM tracking, AI enhanced treatment planning, gammatile for CNS, skin applications & radiopharmaceuticals with demonstrated support from ASTRO president Sameer Keole #ThisIsBrachytherapy

#ABSBrachy25 powerful patient perspectives of courage and resilience! Henschke Award Dr Gerard Morton who shared his training days in Ireland with Radium, pictured with American Brachy past-president Mira Keyes

Bulboclitoris (BC) is an important organ in female sexual health. Contouring of the BC is feasible and would facilitate collection of dosimetric data for those receiving EBRT and brachytherapy for gynaecological malignancies! Stella Lymberis, MD American Brachy #ABSBrachy25

Team Lymberis presented our work at #ABS2025: Bulboclitoris as OAR for Gyn #brachytherapy, ChatGPT4o for brachy patient questions and oncofertility/hormonal outcomes for premenopausal #cervical cancer patients. bravo Andreas Tzavaras, Harika Koduru #nyugrossman

Patients who receive #brachytherapy often say it's not just treatment—it’s a second chance at life. We honor their courage & the care teams guiding them every step of the way. Share your story or tag someone who inspires you. bit.ly/4nQ5b4N #ThisIsBrachytherapy #cancer

Studies have shown that when a woman starts estrogen (or estrogen + progesterone) within 10 years of the onset of menopause, there is a ~25-50% reduction in fatal heart attacks and cardiovascular disease. That's enormously significant, given that heart disease is the leading

My mother was among the 50 million+ women who were denied the potential benefits of hormone replacement therapy. She later suffered multiple bone fractures – so I was struck when a NEJM randomized controlled trial found that HRT started within 10 years of the onset of menopause

TY! Marty Makary MD, MPH FDAWomen panel on #menopause on preventive benefits of MHT for CV, bone density, cognition & safety of vaginal estrogen for sexual function, UTI, longevity and after cancer treatments. Make history U.S. FDA Change the label! youtube.com/live/_2ZRlOivC…

Shame on The New York Times for their biased, unscientific misleading article which does not explain the difference of synthetic estrogen/Progesterone used in WHI and Menopause Hormonal Therapy used today. Do Better #hormonessavelives Women Learn Here: youtube.com/live/_2ZRlOivC…

As a gynecologic radiation oncologist, I have researched the low rate of prescription of vaginal estrogen & Menopausal hormonal therapy amongst premenopausal cervical cancer survivors, which increases cardiovascular death. U.S. FDA Change the label! #hormones #extendsurvival

We’re excited to launch our inaugural Journal Club designed especially for #residents but applicable to all physicians & health care providers with a deep dive into the evolving paradigms in #cervicalcancer care. Join us 08/20. bit.ly/4agtqSq #Brachytherapy

Rad Onc Residents dont miss out on these awards!!!

Excited to share our recent publication on understanding patient priorities for religious and spiritual needs during radiation for gyn cancers! Stella Lymberis, MD Karyn Goodman, MD, MS NYU Radiation Oncology Mount Sinai Radiation Oncology practicalradonc.org/article/S1879-…

I'm attending ASTRO's Annual Meeting #ASTRO25. x.com/ASTRO_org Presenting three presentations on female sexual function (bulboclitoris) in GYN Brachy, spirituality and oncofertility outcomes for cervical cancer patients. Also registered for the ROI 5K and radiopharm

Study of Religion/Spirituality(R/S) history among a diverse women with gyn cancer treated with RT: 82% rated the importance of their faith in coping with stress (5/5) 100% of patients patients reporting that they valued questions addressing the role of R/S in their lives.

Watch this informative journal club I hosted dissecting the latest trials in cervical cancer, KEYNOTE-A18 and INTERLACE. We discussed these neoadjuvant and immunotherapy approaches and put in context with MR image guided brachytherapy. Great job to Dr Krystin Bradley, ABS